The Problems of Anticholinergic Adverse Effects in Older Patients View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1993-07

AUTHORS

Madeline Feinberg

ABSTRACT

The old saying ‘red as a beet, dry as a bone, blind as a bat, hot as a hare, mad as a hatter’ is often quoted when describing the autonomic effects of drugs that block the muscarinic cholinergic system. These effects may be subtle or dramatic, yet can be overlooked or discounted as a natural consequence of old age. Elderly patients can be particularly sensitive to the anticholinergic action of drugs because of physiological and pathophysiological changes that often accompany the aging process. The use of multiple drugs, a common finding in older patients, may result in pharmacodynamic and pharmacokinetic drug interactions that heighten anticholinergic effects. While the classic anticholinergic problems of decreased secretions, slowed gastrointestinal motility, blurred vision, increased heart rate, heat intolerance, sedation and possibly mild confusion, may be uncomfortable for a younger patient in relatively good health, these effects can be disastrous for older patients.Even the most common peripheral anticholinergic complaint of dry mouth can reduce the ability to communicate, predispose to malnutrition, promote mucosal damage, denture misfit or dental caries, and increase the risk of serious respiratory infection secondary to loss of antimicrobial activity of saliva. Mydriasis and the inability to accommodate will impair near vision and may precipitate narrow angle glaucoma in predisposed patients, but less obviously could lead to an increased risk of accidents, including falls. Somatic complaints of constipation and urinary hesitancy, could, in the presence of anticholinergic challenge, result in faecal impaction or urinary retention. Cardiac effects may be poorly tolerated. Increases in heart rate may precipitate or worsen angina. Finally, thermoregulatory impairment induced by anticholinergics, which block the ability to sweat, may lead to life threatening hyperthermia.Central anticholinergic effects range from sedation, mild confusion and inability to concentration to frank delirium. Even mild effects can reduce function and increase dependency. At any level of care, the loss of independence increases the caregiver burden, costs, and most importantly, can negatively affect quality of life.Many age-related and disease-related conditions may predispose elderly patients to anticholinergic drug toxicity. Careful attention to anticholinergic effects when prescribing drugs, patient education, regular review of the entire drug regimen, and familiarity with the signs and symptoms of anticholinergic toxicity will help to reduce the risk of drug-induced problems. More... »

PAGES

335-348

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/00002512-199303040-00004

DOI

http://dx.doi.org/10.2165/00002512-199303040-00004

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1015621468

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/8369593


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholinergic Fibers", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Parasympatholytics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Elder-Health Program, Center for the Study of Pharmacy and Therapeutics for the Elderly, University of Maryland School of Pharmacy, 21201, Baltimore, Maryland, USA", 
          "id": "http://www.grid.ac/institutes/grid.411024.2", 
          "name": [
            "Elder-Health Program, Center for the Study of Pharmacy and Therapeutics for the Elderly, University of Maryland School of Pharmacy, 21201, Baltimore, Maryland, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Feinberg", 
        "givenName": "Madeline", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00003495-198937010-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024913304", 
          "https://doi.org/10.2165/00003495-198937010-00008"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-642-73666-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042607275", 
          "https://doi.org/10.1007/978-3-642-73666-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002512-199101050-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005875965", 
          "https://doi.org/10.2165/00002512-199101050-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00265918", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030251315", 
          "https://doi.org/10.1007/bf00265918"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1993-07", 
    "datePublishedReg": "1993-07-01", 
    "description": "The old saying \u2018red as a beet, dry as a bone, blind as a bat, hot as a hare, mad as a hatter\u2019 is often quoted when describing the autonomic effects of drugs that block the muscarinic cholinergic system. These effects may be subtle or dramatic, yet can be overlooked or discounted as a natural consequence of old age. Elderly patients can be particularly sensitive to the anticholinergic action of drugs because of physiological and pathophysiological changes that often accompany the aging process. The use of multiple drugs, a common finding in older patients, may result in pharmacodynamic and pharmacokinetic drug interactions that heighten anticholinergic effects. While the classic anticholinergic problems of decreased secretions, slowed gastrointestinal motility, blurred vision, increased heart rate, heat intolerance, sedation and possibly mild confusion, may be uncomfortable for a younger patient in relatively good health, these effects can be disastrous for older patients.Even the most common peripheral anticholinergic complaint of dry mouth can reduce the ability to communicate, predispose to malnutrition, promote mucosal damage, denture misfit or dental caries, and increase the risk of serious respiratory infection secondary to loss of antimicrobial activity of saliva. Mydriasis and the inability to accommodate will impair near vision and may precipitate narrow angle glaucoma in predisposed patients, but less obviously could lead to an increased risk of accidents, including falls. Somatic complaints of constipation and urinary hesitancy, could, in the presence of anticholinergic challenge, result in faecal impaction or urinary retention. Cardiac effects may be poorly tolerated. Increases in heart rate may precipitate or worsen angina. Finally, thermoregulatory impairment induced by anticholinergics, which block the ability to sweat, may lead to life threatening hyperthermia.Central anticholinergic effects range from sedation, mild confusion and inability to concentration to frank delirium. Even mild effects can reduce function and increase dependency. At any level of care, the loss of independence increases the caregiver burden, costs, and most importantly, can negatively affect quality of life.Many age-related and disease-related conditions may predispose elderly patients to anticholinergic drug toxicity. Careful attention to anticholinergic effects when prescribing drugs, patient education, regular review of the entire drug regimen, and familiarity with the signs and symptoms of anticholinergic toxicity will help to reduce the risk of drug-induced problems.", 
    "genre": "article", 
    "id": "sg:pub.10.2165/00002512-199303040-00004", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100990", 
        "issn": [
          "1170-229X", 
          "1179-1969"
        ], 
        "name": "Drugs & Aging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "3"
      }
    ], 
    "keywords": [
      "older patients", 
      "anticholinergic effects", 
      "mild confusion", 
      "elderly patients", 
      "heart rate", 
      "central anticholinergic effects", 
      "anticholinergic adverse effects", 
      "narrow-angle glaucoma", 
      "pharmacokinetic drug interactions", 
      "serious respiratory infections", 
      "muscarinic cholinergic system", 
      "drug-induced problems", 
      "level of care", 
      "quality of life", 
      "loss of independence", 
      "disease-related conditions", 
      "urinary hesitancy", 
      "anticholinergic challenge", 
      "frank delirium", 
      "dry mouth", 
      "fecal impaction", 
      "urinary retention", 
      "younger patients", 
      "cardiac effects", 
      "drug regimen", 
      "gastrointestinal motility", 
      "mucosal damage", 
      "respiratory infections", 
      "autonomic effects", 
      "anticholinergic action", 
      "dental caries", 
      "heat intolerance", 
      "pathophysiological changes", 
      "angle glaucoma", 
      "caregiver burden", 
      "anticholinergic toxicity", 
      "cholinergic system", 
      "common finding", 
      "patient education", 
      "drug interactions", 
      "drug toxicity", 
      "patients", 
      "multiple drugs", 
      "thermoregulatory impairment", 
      "older age", 
      "good health", 
      "somatic complaints", 
      "adverse effects", 
      "drugs", 
      "regular review", 
      "sedation", 
      "complaints", 
      "risk", 
      "mild effect", 
      "toxicity", 
      "careful attention", 
      "aging process", 
      "constipation", 
      "angina", 
      "anticholinergics", 
      "delirium", 
      "mydriasis", 
      "regimen", 
      "glaucoma", 
      "caries", 
      "symptoms", 
      "malnutrition", 
      "infection", 
      "intolerance", 
      "secretion", 
      "impairment", 
      "risk of accidents", 
      "care", 
      "impaction", 
      "inability", 
      "age", 
      "effect", 
      "hesitancy", 
      "saliva", 
      "burden", 
      "bone", 
      "antimicrobial activity", 
      "hyperthermia", 
      "signs", 
      "health", 
      "life", 
      "rate", 
      "motility", 
      "loss", 
      "review", 
      "confusion", 
      "findings", 
      "damage", 
      "fall", 
      "mouth", 
      "ability", 
      "levels", 
      "activity", 
      "action", 
      "vision", 
      "increase", 
      "accidents", 
      "changes", 
      "presence", 
      "use", 
      "familiarity", 
      "retention", 
      "function", 
      "quality", 
      "consequences", 
      "bats", 
      "education", 
      "challenges", 
      "conditions", 
      "attention", 
      "independence", 
      "hares", 
      "problem", 
      "interaction", 
      "cost", 
      "system", 
      "natural consequence", 
      "process", 
      "dependency", 
      "beet", 
      "Hatter", 
      "misfit"
    ], 
    "name": "The Problems of Anticholinergic Adverse Effects in Older Patients", 
    "pagination": "335-348", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1015621468"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/00002512-199303040-00004"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "8369593"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/00002512-199303040-00004", 
      "https://app.dimensions.ai/details/publication/pub.1015621468"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:29", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_258.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.2165/00002512-199303040-00004"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00002512-199303040-00004'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00002512-199303040-00004'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00002512-199303040-00004'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00002512-199303040-00004'


 

This table displays all metadata directly associated to this object as RDF triples.

231 TRIPLES      21 PREDICATES      164 URIs      152 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/00002512-199303040-00004 schema:about N0d047df810424e6b98a523ea63fa2787
2 N555f9cb63c8c46f9ab1946650a33e582
3 N9bcf9d19d1f9407fbaf020c82bbdcbc2
4 Nb47a67ab1bdb4004b5db0efb9e25d799
5 Nc312f577c8864d97a3fbac367aa2e703
6 Ne06e18a3ccc34817a1d360d088161507
7 Neb32a4d4f66649c599d80fee3450c7d6
8 anzsrc-for:11
9 anzsrc-for:1115
10 schema:author N0c3dba12557e4062873d6ce546a034f5
11 schema:citation sg:pub.10.1007/978-3-642-73666-7
12 sg:pub.10.1007/bf00265918
13 sg:pub.10.2165/00002512-199101050-00006
14 sg:pub.10.2165/00003495-198937010-00008
15 schema:datePublished 1993-07
16 schema:datePublishedReg 1993-07-01
17 schema:description The old saying ‘red as a beet, dry as a bone, blind as a bat, hot as a hare, mad as a hatter’ is often quoted when describing the autonomic effects of drugs that block the muscarinic cholinergic system. These effects may be subtle or dramatic, yet can be overlooked or discounted as a natural consequence of old age. Elderly patients can be particularly sensitive to the anticholinergic action of drugs because of physiological and pathophysiological changes that often accompany the aging process. The use of multiple drugs, a common finding in older patients, may result in pharmacodynamic and pharmacokinetic drug interactions that heighten anticholinergic effects. While the classic anticholinergic problems of decreased secretions, slowed gastrointestinal motility, blurred vision, increased heart rate, heat intolerance, sedation and possibly mild confusion, may be uncomfortable for a younger patient in relatively good health, these effects can be disastrous for older patients.Even the most common peripheral anticholinergic complaint of dry mouth can reduce the ability to communicate, predispose to malnutrition, promote mucosal damage, denture misfit or dental caries, and increase the risk of serious respiratory infection secondary to loss of antimicrobial activity of saliva. Mydriasis and the inability to accommodate will impair near vision and may precipitate narrow angle glaucoma in predisposed patients, but less obviously could lead to an increased risk of accidents, including falls. Somatic complaints of constipation and urinary hesitancy, could, in the presence of anticholinergic challenge, result in faecal impaction or urinary retention. Cardiac effects may be poorly tolerated. Increases in heart rate may precipitate or worsen angina. Finally, thermoregulatory impairment induced by anticholinergics, which block the ability to sweat, may lead to life threatening hyperthermia.Central anticholinergic effects range from sedation, mild confusion and inability to concentration to frank delirium. Even mild effects can reduce function and increase dependency. At any level of care, the loss of independence increases the caregiver burden, costs, and most importantly, can negatively affect quality of life.Many age-related and disease-related conditions may predispose elderly patients to anticholinergic drug toxicity. Careful attention to anticholinergic effects when prescribing drugs, patient education, regular review of the entire drug regimen, and familiarity with the signs and symptoms of anticholinergic toxicity will help to reduce the risk of drug-induced problems.
18 schema:genre article
19 schema:isAccessibleForFree false
20 schema:isPartOf N39ddd577d2b048c8bf78c0252a5f15b3
21 Na79cf4087ce449e4b4478112008edfb4
22 sg:journal.1100990
23 schema:keywords Hatter
24 ability
25 accidents
26 action
27 activity
28 adverse effects
29 age
30 aging process
31 angina
32 angle glaucoma
33 anticholinergic action
34 anticholinergic adverse effects
35 anticholinergic challenge
36 anticholinergic effects
37 anticholinergic toxicity
38 anticholinergics
39 antimicrobial activity
40 attention
41 autonomic effects
42 bats
43 beet
44 bone
45 burden
46 cardiac effects
47 care
48 careful attention
49 caregiver burden
50 caries
51 central anticholinergic effects
52 challenges
53 changes
54 cholinergic system
55 common finding
56 complaints
57 conditions
58 confusion
59 consequences
60 constipation
61 cost
62 damage
63 delirium
64 dental caries
65 dependency
66 disease-related conditions
67 drug interactions
68 drug regimen
69 drug toxicity
70 drug-induced problems
71 drugs
72 dry mouth
73 education
74 effect
75 elderly patients
76 fall
77 familiarity
78 fecal impaction
79 findings
80 frank delirium
81 function
82 gastrointestinal motility
83 glaucoma
84 good health
85 hares
86 health
87 heart rate
88 heat intolerance
89 hesitancy
90 hyperthermia
91 impaction
92 impairment
93 inability
94 increase
95 independence
96 infection
97 interaction
98 intolerance
99 level of care
100 levels
101 life
102 loss
103 loss of independence
104 malnutrition
105 mild confusion
106 mild effect
107 misfit
108 motility
109 mouth
110 mucosal damage
111 multiple drugs
112 muscarinic cholinergic system
113 mydriasis
114 narrow-angle glaucoma
115 natural consequence
116 older age
117 older patients
118 pathophysiological changes
119 patient education
120 patients
121 pharmacokinetic drug interactions
122 presence
123 problem
124 process
125 quality
126 quality of life
127 rate
128 regimen
129 regular review
130 respiratory infections
131 retention
132 review
133 risk
134 risk of accidents
135 saliva
136 secretion
137 sedation
138 serious respiratory infections
139 signs
140 somatic complaints
141 symptoms
142 system
143 thermoregulatory impairment
144 toxicity
145 urinary hesitancy
146 urinary retention
147 use
148 vision
149 younger patients
150 schema:name The Problems of Anticholinergic Adverse Effects in Older Patients
151 schema:pagination 335-348
152 schema:productId N0b3fbe7988af4c01a9ff3bc8db495aab
153 N84b3f949f2d24767ba85aab6f85d44ce
154 N8bae2290cbf54388815674d3315f2c5a
155 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015621468
156 https://doi.org/10.2165/00002512-199303040-00004
157 schema:sdDatePublished 2022-10-01T06:29
158 schema:sdLicense https://scigraph.springernature.com/explorer/license/
159 schema:sdPublisher Na5a685779da34e55a3a8430ee0b1d6c9
160 schema:url https://doi.org/10.2165/00002512-199303040-00004
161 sgo:license sg:explorer/license/
162 sgo:sdDataset articles
163 rdf:type schema:ScholarlyArticle
164 N0b3fbe7988af4c01a9ff3bc8db495aab schema:name dimensions_id
165 schema:value pub.1015621468
166 rdf:type schema:PropertyValue
167 N0c3dba12557e4062873d6ce546a034f5 rdf:first N8ba020f712864db98d61991b0a269815
168 rdf:rest rdf:nil
169 N0d047df810424e6b98a523ea63fa2787 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Drug Therapy
171 rdf:type schema:DefinedTerm
172 N39ddd577d2b048c8bf78c0252a5f15b3 schema:issueNumber 4
173 rdf:type schema:PublicationIssue
174 N555f9cb63c8c46f9ab1946650a33e582 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Aging
176 rdf:type schema:DefinedTerm
177 N84b3f949f2d24767ba85aab6f85d44ce schema:name doi
178 schema:value 10.2165/00002512-199303040-00004
179 rdf:type schema:PropertyValue
180 N8ba020f712864db98d61991b0a269815 schema:affiliation grid-institutes:grid.411024.2
181 schema:familyName Feinberg
182 schema:givenName Madeline
183 rdf:type schema:Person
184 N8bae2290cbf54388815674d3315f2c5a schema:name pubmed_id
185 schema:value 8369593
186 rdf:type schema:PropertyValue
187 N9bcf9d19d1f9407fbaf020c82bbdcbc2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Cholinergic Fibers
189 rdf:type schema:DefinedTerm
190 Na5a685779da34e55a3a8430ee0b1d6c9 schema:name Springer Nature - SN SciGraph project
191 rdf:type schema:Organization
192 Na79cf4087ce449e4b4478112008edfb4 schema:volumeNumber 3
193 rdf:type schema:PublicationVolume
194 Nb47a67ab1bdb4004b5db0efb9e25d799 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Parasympatholytics
196 rdf:type schema:DefinedTerm
197 Nc312f577c8864d97a3fbac367aa2e703 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Aged
199 rdf:type schema:DefinedTerm
200 Ne06e18a3ccc34817a1d360d088161507 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
201 schema:name Risk Factors
202 rdf:type schema:DefinedTerm
203 Neb32a4d4f66649c599d80fee3450c7d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
204 schema:name Humans
205 rdf:type schema:DefinedTerm
206 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
207 schema:name Medical and Health Sciences
208 rdf:type schema:DefinedTerm
209 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
210 schema:name Pharmacology and Pharmaceutical Sciences
211 rdf:type schema:DefinedTerm
212 sg:journal.1100990 schema:issn 1170-229X
213 1179-1969
214 schema:name Drugs & Aging
215 schema:publisher Springer Nature
216 rdf:type schema:Periodical
217 sg:pub.10.1007/978-3-642-73666-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042607275
218 https://doi.org/10.1007/978-3-642-73666-7
219 rdf:type schema:CreativeWork
220 sg:pub.10.1007/bf00265918 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030251315
221 https://doi.org/10.1007/bf00265918
222 rdf:type schema:CreativeWork
223 sg:pub.10.2165/00002512-199101050-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005875965
224 https://doi.org/10.2165/00002512-199101050-00006
225 rdf:type schema:CreativeWork
226 sg:pub.10.2165/00003495-198937010-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024913304
227 https://doi.org/10.2165/00003495-198937010-00008
228 rdf:type schema:CreativeWork
229 grid-institutes:grid.411024.2 schema:alternateName Elder-Health Program, Center for the Study of Pharmacy and Therapeutics for the Elderly, University of Maryland School of Pharmacy, 21201, Baltimore, Maryland, USA
230 schema:name Elder-Health Program, Center for the Study of Pharmacy and Therapeutics for the Elderly, University of Maryland School of Pharmacy, 21201, Baltimore, Maryland, USA
231 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...